Loading…

Advances in the development of a targeted N-Terminal Domain androgen receptor (AR) degrader (ANITAC) for the treatment of prostate cancer

Saved in:

Bibliographic Details
Published in:	European journal of cancer (1990) 2022-10, Vol.174, p.S37-S37
Main Authors:	Hong, N.H., Biannic, B., Virsik, P., Zhou, H.J., Le Moigne, R.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!